Study of the efficacy and safety of thiotriazoline in patients with dyslipoproteinemia
Journal: Scientific review, Науковий огляд, Научное обозрение (Vol.36, No. 4)Publication Date: 2017-05-31
Authors : Belay I.M.; Demchenko V.O.; Krasko N.P.; Ostapenko; A.A.;
Page : 42-46
Keywords : thiotriazolinum; dislipoproteidemic syndrome; antiatherosclerotic action; antioxidant acntion;
Abstract
The article shows research of hypolipidemic and antioxidant actions of thiotriazolinum in dislipoproteidemic syndrome. It was found that thiotriazolinum possess hypocholesterol, hypotriglyceridemic, hypo-β-lipoproteidemic, antiatheromatous and antioxidant effect in the experiment and can be used to treatment dislipoproteidemic syndrome.
Other Latest Articles
- Recreational and healt-improving forests of volyn region
- Analysis of the main theories of ethnic groups
- Professional recruitment as a guarantee of success of the enterprise
- State and evaluation of environment in Ukraine
- About some peculiarities of calculation of protection zones of wire air-termination lightning rod
Last modified: 2017-05-31 15:04:17